128 related articles for article (PubMed ID: 11944335)
21. [A panel of monoclonal antibodies against human lymphocyte antigens].
Filatov AV; Bachurin PS; Markova NA; Surnakova NE
Eksp Onkol; 1989; 11(2):28-32. PubMed ID: 2737128
[TBL] [Abstract][Full Text] [Related]
22. [Antigen differences of genetic variants Abent+ and Abent- poliovirus vaccine strain of III type].
Shyrobokov VP; Kostenko IH; Nikolaienko IV
Mikrobiol Z; 2003; 65(4):29-36. PubMed ID: 14618784
[TBL] [Abstract][Full Text] [Related]
23. [Establishment of 25 hybridomas secreting monoclonal antibodies against type 1 polio viruses (Sabin strain) and their application in antigenic analysis].
Gu FZ; Mu GF; Wang YA
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):157-61. PubMed ID: 6098380
[No Abstract] [Full Text] [Related]
24. Production of monoclonal antibodies against whole virus particles of foot-and-mouth disease virus serotype O and A and their potential use in quantification of intact virus for vaccine manufacture.
Yang M; Holland H; Clavijo A
Vaccine; 2008 Jun; 26(27-28):3377-82. PubMed ID: 18513841
[TBL] [Abstract][Full Text] [Related]
25. [Preparation and identification of the monoclonal antibodies against VP1 capsid protein of Enterovius 71].
Yi Y; Guo MZ; Shen XL; Yu T; Jia ZY; Bi SL; Li XL; Chen SY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):62-4. PubMed ID: 19799022
[TBL] [Abstract][Full Text] [Related]
26. Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies.
Crainic R; Couillin P; Cabau N; Boue A; Horodniceanu F
Dev Biol Stand; 1981; 50():229-34. PubMed ID: 6176486
[TBL] [Abstract][Full Text] [Related]
27. Production and characterization of neutralizing monoclonal antibodies against poliovirus type 1, 2, and 3.
Payment P; Trudel M; Thibodeau L; Lecomte J
Can J Microbiol; 1989 May; 35(5):550-3. PubMed ID: 2545322
[TBL] [Abstract][Full Text] [Related]
28. Different neutralization efficiency of neutralizing monoclonal antibodies against avian influenza H5N1 virus to virus strains from different hosts.
Huang H; Dan H; Zhou Y; Yu Z; Fan H; Tong T; Jin M; Chen H
Mol Immunol; 2007 Feb; 44(5):1052-5. PubMed ID: 16965815
[TBL] [Abstract][Full Text] [Related]
29. Preliminary studies on antigenic variation of poliovirus using neutralizing monoclonal antibodies.
Guo R; Tang EH; Wang H; Yang XF; Liu MY; Qin HX; Li QH; Zhuang JY; Liu KM
J Gen Virol; 1987 Apr; 68 ( Pt 4)():989-94. PubMed ID: 3033136
[TBL] [Abstract][Full Text] [Related]
30. [Type-specific and strain-specific monoclonal antibody against type 1 poliovirus].
Gu FZ
Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):69-72. PubMed ID: 6305464
[No Abstract] [Full Text] [Related]
31. [Isolation of cell hybrids secreting specific antibodies against bovine enteric coronavirus (author's transl)].
Roseto A; Vautherot JF; Bobulesco P; Guillemin MC
C R Seances Acad Sci III; 1982 Feb; 294(8):347-52. PubMed ID: 6807513
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
[TBL] [Abstract][Full Text] [Related]
33. The pathogenesis of poliomyelitis: what we don't know.
Nathanson N
Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
[TBL] [Abstract][Full Text] [Related]
34. [Intratypical antigenic differentiation of poliovirus strains circulating in Mali by means of cross-adsorbed sera].
Pervikov IuV; Fafana Ia; Koldoba LG
Vopr Virusol; 1978; (4):470-3. PubMed ID: 86237
[TBL] [Abstract][Full Text] [Related]
35. Intertypic cross-neutralization of polioviruses by human monoclonal antibodies.
Uhlig H; Dernick R
Virology; 1988 Mar; 163(1):214-7. PubMed ID: 2831657
[TBL] [Abstract][Full Text] [Related]
36. [Isolation of monoclonal antibodies to influenza viruses].
Iamnikova SS; Kurochkin SN; Gnuchev NV; Iurkif VA; Severin ES
Vopr Virusol; 1983; 28(1):21-4. PubMed ID: 6845713
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of an ELISA kit made in our laboratory for intratypic discrimination of poliovirus type 1 strains isolated from acute flask paralysis].
Ozkaya E; Arita M
Mikrobiyol Bul; 2002 Jan; 36(1):71-7. PubMed ID: 12476769
[TBL] [Abstract][Full Text] [Related]
38. Improvement of methods for intratypic differentiation of polioviruses. III. Neutralization test with cross-adsorbed sera for differentiation between wild and vaccine strains of polioviruses.
Pervikov YV; Chumakov MP; Voroshilova MK; Rubin SG; Savinskaya SS; Gracheva LA
Arch Gesamte Virusforsch; 1974; 46(1-2):71-7. PubMed ID: 4374169
[No Abstract] [Full Text] [Related]
39. Development and characterization of monoclonal antibodies against FMD virus type Asia-1 and determination of antigenic variations in the field strains.
Rana SK; Bagchi T
Vet Immunol Immunopathol; 2008 Apr; 122(3-4):241-9. PubMed ID: 18291535
[TBL] [Abstract][Full Text] [Related]
40. Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody.
Yang DP; Zielinska E; Quiroz J; Madore D; Rappaport R
Biologicals; 2007 Jun; 35(3):183-7. PubMed ID: 17241789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
